Sign In
Buy ZYME
$22.86
-0.260 (-1.12%)
At Close: Jul 24, 2026
Zymeworks Inc. $ZYME Shares Sold by Citigroup Inc.
03:36am, Monday, 09'th Mar 2026
Citigroup Inc. trimmed its position in shares of Zymeworks Inc. (NASDAQ: ZYME) by 24.5% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Co
Zymeworks FY25 Review: From Milestone Volatility To 2026 Upside
10:45am, Wednesday, 04'th Mar 2026
Zymeworks Inc. (ZYME) reported weak Q4 results, highlighting the volatility of its milestone-driven revenue model and underscoring execution risk ahead of commercialization. Despite top-line misses, Z
Zymeworks Inc. (NASDAQ:ZYME) Given Average Rating of “Moderate Buy” by Brokerages
04:13am, Wednesday, 04'th Mar 2026
Shares of Zymeworks Inc. (NASDAQ: ZYME - Get Free Report) have been assigned an average rating of "Moderate Buy" from the fourteen ratings firms that are covering the stock, Marketbeat Ratings reports
Zymeworks Q4 Earnings Call Highlights
01:34am, Wednesday, 04'th Mar 2026
Zymeworks (NASDAQ: ZYME) executives used the company's fourth-quarter 2025 results call to highlight updated clinical data for its partnered HER2 antibody zanidatamab, outline a new royalty-backed fin
Zymeworks Inc. (ZYME) Q4 2025 Earnings Call Transcript
09:17pm, Monday, 02'nd Mar 2026
Zymeworks Inc. (ZYME) Q4 2025 Earnings Call Transcript
Zymeworks Inc. (ZYME) Reports Q4 Loss, Lags Revenue Estimates
08:15am, Monday, 02'nd Mar 2026
Zymeworks Inc. (ZYME) came out with a quarterly loss of $0.55 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to a loss of $0.31 per share a year ago.
Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing
06:10am, Monday, 02'nd Mar 2026
NEW YORK and VANCOUVER, British Columbia, March 02, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) and Zymeworks Inc. (Nasdaq: ZYME) today announced an agreement for $250 million in fundin
Zymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing
06:01am, Monday, 02'nd Mar 2026
VANCOUVER, British Columbia and NEW YORK, March 02, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME) and Royalty Pharma plc (Nasdaq: RPRX) today announced an agreement for $250 million in fundi
Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results
06:00am, Monday, 02'nd Mar 2026
VANCOUVER, British Columbia, March 02, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets, while developing a diverse pi
Investor Slashes $70 Million From Zymeworks as Stock Jumps 60% in a Year
12:53pm, Sunday, 22'nd Feb 2026
Redmile Group sold 3,214,096 ZYME shares, estimated at $70.10 million based on quarterly average prices. Meanwhile, the quarter-end value of the Zymeworks stake decreased by $50.35 million, reflecting
Zymeworks (NYSE:ZYME) and Zomedica (OTC:ZOMDF) Critical Review
01:52am, Friday, 13'th Feb 2026
Zomedica (OTC: ZOMDF - Get Free Report) and Zymeworks (NYSE: ZYME - Get Free Report) are both small-cap manufacturing companies, but which is the better stock? We will contrast the two companies based
Zymeworks To Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on March 2, 2026
06:00am, Thursday, 12'th Feb 2026
VANCOUVER, British Columbia, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets, while developing a diverse pip
Contrasting Zymeworks (NASDAQ:ZYME) and Generex Biotechnology (OTCMKTS:GNBT)
01:44am, Friday, 06'th Feb 2026
Zymeworks (NASDAQ: ZYME - Get Free Report) and Generex Biotechnology (OTCMKTS:GNBT - Get Free Report) are both small-cap manufacturing companies, but which is the better business? We will compare the
Zymeworks Announces Participation in Upcoming Investor Conferences
06:00am, Tuesday, 27'th Jan 2026
VANCOUVER, British Columbia, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets, while developing a diverse pip
Mark Hollywood Sells 6,120 Shares of Zymeworks (NYSE:ZYME) Stock
05:16am, Thursday, 15'th Jan 2026
Zymeworks Inc. (NYSE: ZYME - Get Free Report) COO Mark Hollywood sold 6,120 shares of the company's stock in a transaction that occurred on Monday, January 12th. The stock was sold at an average price
